Active Ingredient(s): Galsulfase
FDA Approved: * May 31, 2005
Pharm Company: * BIOMARIN
Category: Enzymes

Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body.[1] Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.[1] ERT is available for some lysosomal storage diseases: Gaucher disease, Fabry disease, MPS I, MPS II (Hunter syndrome), MPS VI and Pompe disease.[1] ERT does not correct the underlying genetic defect, but it incr... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Naglazyme 5 mg/5ml Intravenous Solution
NDC: 68135-020
Biomarin Pharmaceutical Inc.